Myeloid derived suppressor cells

By T. Waldron, Jon G. Quatromoni, Tatiana A. Karakasheva, S. Singhal, A. Rustgi. Oncoimmunology, 2013

938 citations recorded by the source corpus.

The goal of achieving measurable response with cancer immunotherapy requires counteracting the immunosuppressive characteristics of tumors. One of the mechanisms that tumors utilize to escape immunosurveillance is the activation of myeloid derived suppressor cells (MDSCs). Upon activation by tumor-derived signals, MDSCs inhibit the ability of the host to mount an anti-tumor immune response via their capacity to suppress both the innate and adaptive immune systems. Despite their relatively recent discovery and characterization, anti-MDSC agents have been identified, which may improve immunotherapy efficacy.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/f201f4d95ed80090e2005e49115977fff1f76893

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. A. Mócsai

In Oncology

  1. A. Mócsai

Citations in the corpus